Polymorphism of tumor suppressor gene (p53) Codon 72 in Iraqi patients with acute myocardial infarction
AbstractObjectives According to previous studies, the aim of the presented work is to investigate the possible association between the codon 72 polymorphism (Pro72Arg, rs1042522) of the tumor suppressor gene (p53) with acute myocardial infarction (AMI) in Iraqi patients of Karbala province.Methods A total of 58 smokers and non-smokers patients with AMI diagnosed by clinical history, electrocardiography and troponin I level and another 35 healthy controls were included in this study. The (Pro72Arg) polymorphism of the p53 gene was evaluated by molecular techniques.Results The genotype distribution for the Pro72Arg variant of the p53 gene in AMI non-smokers patients (PP: n = 9, 47.4%; RP: n = 2, 10.5%; RR: n = 8, 42.1%) and controls (PP: n = 9, 50.0%; RP: n = 9, 50.0%; RR: n = 0, 0.0%) was significantly different (p = 0.002). and the genotype distribution for the Pro72Arg variant of the p53 gene in AMI smokers patients (PP: n = 20, 51.3%; RP: n = 1, 2.6%; RR: n = 18, 46.2%) and controls (PP: n = 14, 82.4%; RP: n = 2, 11.8%; RR: n = 1, 5.9%) was significantly different (p = 0.009).Conclusion These findings suggest that the Pro72Arg polymorphism of tumor suppressor p53 gene is associated with AMI patient studies.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.Copyright of the manuscripts is retained by the authors. Authors grant Nab'a Al-Hayat Foundation for Medical Sciences and Health Care - Press, an exclusive unlimited license to publish the article under a Creative Commons Attribution-NonCommercial 3.0 and identify Nab'a Al-Hayat Foundation for Medical Sciences and Health Care - Press as the sole publisher. Submission of an article for publication implies the authors’ consent to publication under the applicable Creative Commons license and the terms and conditions of the Publisher’s Licensing Agreement.